Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-08-067341
Filing Date
2008-03-27
Accepted
2008-03-27 17:19:40
Documents
11
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1426893
2 EMPLOYMENT AGREEMENT, BY AND BETWEEN THE REGISTRANT AND ROGER MILLER dex107.htm EX-10.7 43800
3 EMPLOYMENT AGREEMENT, BY AND BETWEEN THE REGISTRANT AND MONA HAYNES dex108.htm EX-10.8 38158
4 SECOND AMENDMENT TO LEASE, BY AND BETWEEN THE REGISTRANT AND AMERICAN TWINE dex10112.htm EX-10.11.2 14637
5 AMENDMENT NO. 1 TO MANUFACTURNING SERVICES AGREEMENT, DATED MARCH 3, 2008 dex10141.htm EX-10.14.1 14812
6 LIST OF SUBSIDIARIES dex211.htm EX-21.1 3614
7 CERTIFICATION OF CEO PURSUANT TO SECTION 302 dex311.htm EX-31.1 9842
8 CERTIFICATION OF CFO PURSUANT TO SECTION 302 dex312.htm EX-31.2 9839
9 CERTIFICATION OF CEO PURSUANT TO SECTION 906 dex321.htm EX-32.1 3482
10 CERTIFICATION OF CFO PURSUANT TO SECTION 906 dex322.htm EX-32.2 3475
11 GRAPHIC g38300g97r11.jpg GRAPHIC 55979
  Complete submission text file 0001193125-08-067341.txt   1647261
Mailing Address 222 THIRD AVENUE SUITE 2300 CAMBRIDGE MA 02142
Business Address 222 THIRD AVENUE SUITE 2300 CAMBRIDGE MA 02142 (617) 557-9020
Targanta Therapeutics Corp. (Filer) CIK: 0001398161 (see all company filings)

EIN.: 203971077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33730 | Film No.: 08715934
SIC: 2834 Pharmaceutical Preparations